** Shares of IDT Australia IDT.AX rise 9.5% to A$0.115
** Stock hits its highest level since Nov 13, 2024
** The pharma manufacturer sees 1HFY25 revenue to jump by 82% to A$10.5 mln ($6.57 mln)
** Co says total unaudited quarterly revenue nearly doubles to A$5.3 mln from a year earlier
** Co says growth largely driven by significant increase in Advanced Therapies business
** Stock has gained 4.6%, YTD
($1 = 1.5972 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。